Finance

Lists
600976:SHA
Jianmin Pharmaceutical Group Co Ltd
27,08 CN¥
0,00%
(0,00) 1D
15 қаз., 15:00:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600976...
Mkt. cap
4,15 млрд
Avg. vol.
1,41 млн
Volume
0,00
Dividend
3,32%
Quarterly dividend
0,22 CN¥
Ex-dividend date
2026 ж. 28 сәу.
P/E ratio
13,00
52-wk high
40,73 CN¥
52-wk low
24,68 CN¥
EPS
2,08 CN¥
Shares outstanding
153,40 млн
No. of employees
2 мың
Mkt. cap
4,15 млрд
Avg. vol.
1,41 млн
Volume
0,00
Dividend
3,32%
Quarterly dividend
0,22 CN¥
Ex-dividend date
2026 ж. 28 сәу.
P/E ratio
13,00
52-wk high
40,73 CN¥
52-wk low
24,68 CN¥
EPS
2,08 CN¥
Shares outstanding
153,40 млн
No. of employees
2 мың
News stories
From web sources and news partners
About Jianmin Pharmaceutical Group Co Ltd
CEO-
Employees2,26 мың
Founded1637
Headquarters-
SectorPharmaceutical industry
Websitewhjm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
747,33 млн
817,97 млн
873,07 млн
738,07 млн
Cost of goods sold
308,14 млн
368,28 млн
303,81 млн
301,54 млн
Cost of revenue
308,14 млн
368,28 млн
303,81 млн
301,54 млн
Research and development expenses
25,35 млн
20,36 млн
21,28 млн
19,77 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
380,38 млн
358,68 млн
466,52 млн
334,30 млн
Operating expense
397,96 млн
414,67 млн
495,06 млн
358,84 млн
Total operating expenses
706,10 млн
782,95 млн
798,87 млн
660,38 млн
Operating income
41,23 млн
35,03 млн
74,20 млн
77,70 млн
Other non operating income
1,12 млн
4,29 млн
-479,82 м.
-132,33 м.
EBT including unusual items
66,53 млн
85,30 млн
97,54 млн
100,94 млн
EBT excluding unusual items
75,14 млн
51,48 млн
85,01 млн
90,41 млн
Income tax expense
298,91 м.
8,69 млн
9,23 млн
10,66 млн
Effective tax rate
0,45%
10,18%
9,46%
10,56%
Other operating expenses
-7,77 млн
18,05 млн
7,27 млн
4,77 млн
Net income
65,11 млн
74,10 млн
87,73 млн
89,48 млн
Net profit margin
8,71%
9,06%
10,05%
12,12%
Earnings per share
-
-
-
-
Interest and investment income
35,73 млн
17,09 млн
13,91 млн
14,82 млн
Interest expense
-2,94 млн
-4,93 млн
-2,62 млн
-1,98 млн
Net interest expenses
32,79 млн
12,16 млн
11,29 млн
12,84 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
49,63 млн
44,41 млн
83,59 млн
91,27 млн
Gain or loss from assets sale
-342,53 м.
154,53 м.
-
392,72 м.
AI content may include mistakes. Learn more
Google қолданбалары